Aquestive Therapeutics (AQST) Net Equity Issued and Repurchased (2020 - 2021)
Aquestive Therapeutics' (AQST) quarterly Net Equity Issued and Repurchased came in at $9.9 million in Q1 2021, up 63.35% quarter-over-quarter from $6.1 million in Q4 2020.
Aquestive Therapeutics (AQST) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends
Aquestive Therapeutics' Net Equity Issued and Repurchased history runs 2 years deep, the most recent figure standing at $9.9 million for Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 500,000.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 23.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Aquestive Therapeutics | 462.24 Mn | 462.24 Mn | 13.47 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 9.89 Mn |
| Mar 31, 2021 | 9.89 Mn |
| Dec 31, 2020 | 6.06 Mn |
| Dec 31, 2020 | 6.06 Mn |